{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001460602","name":"Orgenesis Inc.","summary":"Orgenesis Inc. is a global biotech company focused on cell and gene therapies (CGTs) using a Decentralized Cell Processing (DCP) Platform that enables automated, compliant production at or near patient care sites. The company develops and commercializes platforms including Koligo (pancreatic islets), CAR-T8-TOR (CAR-T), Icellator2 (SVF), TROJAN (MSC oncolytic virus), LYMVADOR (TILs), HEMOSTART (HSCs), IdenTT (dendritic vaccines), Mida (iPSC), and an exosomes platform, targeting hospitals and industry partners globally.","people":[],"products":[{"name":"Koligo Platform","type":"platform","description":"FDA-cleared pancreatic islets cell therapy platform with over 80 patients treated at US hospitals."},{"name":"CAR-T8-TOR Platform","type":"platform","description":"CAR-T cell therapy platform with over 200 patients treated in Asia."},{"name":"Icellator2 Platform","type":"platform","description":"Stromal Vascular Fraction platform with 70+ US patients in FDA-approved trials and 1,750+ globally in eleven indications."},{"name":"TROJAN Platform","type":"platform","description":"MSC oncolytic virus platform treating 16 pediatric and adult patients with relapsed/refractory solid tumors in Europe."},{"name":"LYMVADOR Platform","type":"platform","description":"Tumor-infiltrating lymphocytes platform approved for clinical trials in Israel."},{"name":"HEMOSTART Platform","type":"platform","description":"Hematopoietic stem cells platform potentially eligible for EU clinical trial cost support."},{"name":"IdenTT Platform","type":"platform","description":"Dendritic cell vaccine production platform."},{"name":"Mida Platform","type":"platform","description":"Induced pluripotent stem cell (iPSC) production platform developed by MIDA Biotech BV."},{"name":"Exosomes Production Platform","type":"platform","description":"Platform for exosome production as part of the DCP portfolio."},{"name":"DCP Platform","type":"platform","description":"Decentralized Cell Processing hub-and-spoke infrastructure enabling standardized, automated CGT production at or near patient care sites."}],"partnerships":[{"partner_name":"Hospitals and research centers (unnamed)","partnership_type":"strategic","description":"Partnerships to develop and adapt cell and gene therapies to the DCP platform and provide standardized production platforms commercially.","start_date":null}],"affiliations":[],"origin":{"leaf":"d2b2ca8f50e0bbc19b41313be7cd7fd23664043013e33692c1ffc2685cbef7c0","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"2894be86cc753a7bf721fa3cabf919d938fe971832d13cf4a84570162c02dfed","parent":"f94045b2ac841baa496459493100d65e8d821f3712e1aa986db1fd3d5a502ab7","source":"0001493152-26-012845","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256() || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":500,"hourly_limit":500,"remaining":0,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}